메뉴 건너뛰기




Volumn 3, Issue 2, 2015, Pages 159-165

Treatment of skeletal metastases with 223Ra-chloride

Author keywords

Bone metastases; Prostate cancer; Radiopharmaceuticals; Radium; Symptomatic skeletal event

Indexed keywords

ABIRATERONE; ABIRATERONE ACETATE; BISPHOSPHONIC ACID DERIVATIVE; CABAZITAXEL; DOCETAXEL; DOXORUBICIN; ENZALUTAMIDE; LEXIDRONAM SAMARIUM SM 153; RADIUM CHLORIDE RA 223; SIPULEUCEL T; ZOLEDRONIC ACID;

EID: 84952992052     PISSN: 22815872     EISSN: 22817565     Source Type: Journal    
DOI: 10.1007/s40336-015-0103-5     Document Type: Review
Times cited : (1)

References (29)
  • 1
    • 84952995689 scopus 로고    scopus 로고
    • Howlader N, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2014) SEER Cancer Statistics Review, 1975–2011. National Cancer Institute, Bethesda
    • Howlader N, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2014) SEER Cancer Statistics Review, 1975–2011. National Cancer Institute, Bethesda
  • 4
    • 34548584066 scopus 로고    scopus 로고
    • Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer
    • PID: 17262196
    • DePuy V, Anstrom KJ, Castel LD, Schulman KA, Weinfurt KP, Saad F (2007) Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer. Support Care Cancer 15:869–876. doi:10.1007/s00520-006-0203-x
    • (2007) Support Care Cancer , vol.15 , pp. 869-876
    • DePuy, V.1    Anstrom, K.J.2    Castel, L.D.3    Schulman, K.A.4    Weinfurt, K.P.5    Saad, F.6
  • 11
    • 0023751783 scopus 로고
    • Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma
    • COI: 1:STN:280:DyaL1M%2FjtVOrug%3D%3D, PID: 2460352
    • Buchali K, Correns HJ, Schuerer M, Schnorr D, Lips H, Sydow K (1988) Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma. Eur J Nucl Med 14:349–351
    • (1988) Eur J Nucl Med , vol.14 , pp. 349-351
    • Buchali, K.1    Correns, H.J.2    Schuerer, M.3    Schnorr, D.4    Lips, H.5    Sydow, K.6
  • 12
    • 33746883985 scopus 로고    scopus 로고
    • Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease
    • PID: 16985930
    • Sartor O (2004) Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease. Rev Urol 6(Suppl 10):S3–S12
    • (2004) Rev Urol , vol.6 , pp. S3-S12
    • Sartor, O.1
  • 13
    • 33746707858 scopus 로고    scopus 로고
    • 223Ra: adjuvant or alternative to conventional modalities?
    • COI: 1:CAS:528:DC%2BD28XhtFWhsbfK, PID: 17062709
    • 223Ra: adjuvant or alternative to conventional modalities? Clin Cancer Res 12:6250s–6257s. doi:10.1158/1078-0432.ccr-06-0841
    • (2006) Clin Cancer Res , vol.12 , pp. 6250s-6257s
    • Bruland, O.S.1    Nilsson, S.2    Fisher, D.R.3    Larsen, R.H.4
  • 16
    • 0036606104 scopus 로고    scopus 로고
    • Significant antitumor effect from bone-seeking, alpha-particle-emitting (223) Ra demonstrated in an experimental skeletal metastases model
    • COI: 1:CAS:528:DC%2BD38XksVyqsrY%3D, PID: 12036923
    • Henriksen G, Breistol K, Bruland OS, Fodstad O, Larsen RH (2002) Significant antitumor effect from bone-seeking, alpha-particle-emitting (223) Ra demonstrated in an experimental skeletal metastases model. Cancer Res 62:3120–3125
    • (2002) Cancer Res , vol.62 , pp. 3120-3125
    • Henriksen, G.1    Breistol, K.2    Bruland, O.S.3    Fodstad, O.4    Larsen, R.H.5
  • 18
    • 20644447798 scopus 로고    scopus 로고
    • First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases
    • COI: 1:CAS:528:DC%2BD2MXltFeksrc%3D, PID: 15958630
    • Nilsson S, Larsen RH, Fossa SD, Balteskard L, Borch KW, Westlin JE, Salberg G, Bruland OS (2005) First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases. Clin Cancer Res 11:4451–4459. doi:10.1158/1078-0432.ccr-04-2244
    • (2005) Clin Cancer Res , vol.11 , pp. 4451-4459
    • Nilsson, S.1    Larsen, R.H.2    Fossa, S.D.3    Balteskard, L.4    Borch, K.W.5    Westlin, J.E.6    Salberg, G.7    Bruland, O.S.8
  • 21
    • 84858706749 scopus 로고    scopus 로고
    • A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
    • COI: 1:CAS:528:DC%2BC38Xkt1Gmt78%3D, PID: 22341993
    • Nilsson S, Strang P, Aksnes AK, Franzen L, Olivier P, Pecking A, Staffurth J, Vasanthan S, Andersson C, Bruland OS (2012) A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. Eur J Cancer 48:678–686. doi:10.1016/j.ejca.2011.12.023
    • (2012) Eur J Cancer , vol.48 , pp. 678-686
    • Nilsson, S.1    Strang, P.2    Aksnes, A.K.3    Franzen, L.4    Olivier, P.5    Pecking, A.6    Staffurth, J.7    Vasanthan, S.8    Andersson, C.9    Bruland, O.S.10
  • 22
    • 84871926771 scopus 로고    scopus 로고
    • A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer
    • COI: 1:CAS:528:DC%2BC38XhsVSltLvP, PID: 23000088
    • Parker CC, Pascoe S, Chodacki A, O’Sullivan JM, Germa JR, O’Bryan-Tear CG, Haider T, Hoskin P (2013) A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer. Eur Urol 63:189–197. doi:10.1016/j.eururo.2012.09.008
    • (2013) Eur Urol , vol.63 , pp. 189-197
    • Parker, C.C.1    Pascoe, S.2    Chodacki, A.3    O’Sullivan, J.M.4    Germa, J.R.5    O’Bryan-Tear, C.G.6    Haider, T.7    Hoskin, P.8
  • 25
    • 84908594586 scopus 로고    scopus 로고
    • Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial
    • COI: 1:CAS:528:DC%2BC2cXhsl2hu7fE, PID: 25439694
    • Hoskin P, Sartor O, O’Sullivan JM, Johannessen DC, Helle SI, Logue J, Bottomley D, Nilsson S, Vogelzang NJ, Fang F, Wahba M, Aksnes AK, Parker C (2014) Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial. Lancet Oncol 15:1397–1406. doi:10.1016/s1470-2045(14)70474-7
    • (2014) Lancet Oncol , vol.15 , pp. 1397-1406
    • Hoskin, P.1    Sartor, O.2    O’Sullivan, J.M.3    Johannessen, D.C.4    Helle, S.I.5    Logue, J.6    Bottomley, D.7    Nilsson, S.8    Vogelzang, N.J.9    Fang, F.10    Wahba, M.11    Aksnes, A.K.12    Parker, C.13
  • 27
    • 70349785587 scopus 로고    scopus 로고
    • Incidence of leukaemia and other malignant diseases following injections of the short-lived alpha-emitter 224Ra into man
    • PID: 19475414
    • Wick RR, Atkinson MJ, Nekolla EA (2009) Incidence of leukaemia and other malignant diseases following injections of the short-lived alpha-emitter 224Ra into man. Radiat Environ Biophys 48:287–294. doi:10.1007/s00411-009-0227-y
    • (2009) Radiat Environ Biophys , vol.48 , pp. 287-294
    • Wick, R.R.1    Atkinson, M.J.2    Nekolla, E.A.3
  • 28
    • 0032733453 scopus 로고    scopus 로고
    • Malignancies in patients treated with high doses of radium-224
    • COI: 1:CAS:528:DyaK1MXnvFynsrw%3D, PID: 10564925
    • Nekolla EA, Kellerer AM, Kuse-Isingschulte M, Eder E, Spiess H (1999) Malignancies in patients treated with high doses of radium-224. Radiat Res 152:S3–S7
    • (1999) Radiat Res , vol.152 , pp. S3-S7
    • Nekolla, E.A.1    Kellerer, A.M.2    Kuse-Isingschulte, M.3    Eder, E.4    Spiess, H.5
  • 29
    • 84952993221 scopus 로고    scopus 로고
    • Effects of radium-223 dichloride (Ra-223) on risk for hospitalization and health care resource use in the phase 3 ALSYMPCA trial
    • Cislo P, Reuning-Scherer J (2014) Effects of radium-223 dichloride (Ra-223) on risk for hospitalization and health care resource use in the phase 3 ALSYMPCA trial. ASCO quality care symposium
    • (2014) ASCO quality care symposium
    • Cislo, P.1    Reuning-Scherer, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.